Summary
The University of Helsinki is inviting applications for a Doctoral Researcher position in the ImmunoViroTherapy Lab at the Faculty of Pharmacy. The position focuses on the generation and optimization of oncolytic viruses for the treatment of glioblastoma (GBM) as part of the MSCA Doctoral Network project “INTRABRAIN.”
Doctoral Researcher in Oncolytic Viruses for GBM Treatment, University of Helsinki, Finland
Designation
Position: Doctoral Researcher
Duration: Full-time, funded for three years
| Detail | Information |
|---|---|
| Research Area | Development and validation of oncolytic viruses for GBM |
| Location | University of Helsinki, Viikki Campus, Finland |
| Salary | €3,639.84 per month before taxes + allowances |
Eligibility/Qualification
- Must be in the first four years of research career (no doctoral degree awarded yet).
- Must not have resided in Finland for more than 12 months in the last 3 years.
- A Master’s degree in Pharmaceutical Sciences, Biotechnology, Molecular Biology, Biomedical Engineering, Nanomedicine, Pharmacy, Pharmaceutical Chemistry, or related field.
- Proficient in both written and spoken English.
Job Description
The successful candidate will:
- Generate and validate novel recombinant oncolytic adenovirus variants.
- Evaluate efficacy through in vitro and in vivo experiments.
- Analyze immune responses and antigenic profiles of treated tumors.
- Scale up promising viral constructs to production-ready systems.
- Participate in secondments to gain expertise in drug delivery technologies.
How to Apply
Submit your application as a single PDF file via the University of Helsinki Recruitment System, including:
- INTRABRAIN DC application form
- Curriculum Vitae (max 2 pages)
- Cover letter (max 1 page)
- Master’s degree certificate and transcript
- Proof of English proficiency
- Contact information for two referees
- List of publications, if applicable.
Last Date to Apply
Application Deadline: May 28, 2026, at 23:59 (Europe/Helsinki time)
